Skip to main content
Clinical Trials/ITMCTR2200005812
ITMCTR2200005812
Not yet recruiting
Phase 1

A Randomized Controlled Study on the Effect of Acupuncture Intervention in Advance on the Efficacy of Moderate to Severe Seasonal Allergic Rhinitis

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Seasonal Allergic Rhinitis
Sponsor
Dongzhimen Hospital, Beijing University of Traditional Chinese Medicine
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional study
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • (1\) Meet the diagnostic criteria of moderate and severe seasonal allergic rhinitis;
  • (2\) Subjects with positive reactions to seasonal inhalation allergens such as pollen and fungi in skin prick test;
  • (3\) Subjects with a history of seasonal allergic rhinitis for at least 2 yearswho have a fixed onset time each year and are currently in remission;
  • (4\) The average total nasal symptom score(TNSS)\=4 during the episode in the past year;
  • (5\) Subjects aged between 18\-65 years old;
  • (6\) Subjects who volunteer to participate in the clinical study, and are able to answer relevant scale questions truthfully as required, recorded the use of anti\-allergy drugs, and signed informed consent.
  • Only those who meet the above six items can be included.

Exclusion Criteria

  • (1\) Subjects who have a history of chronic paranasal sinusitis, or who are found to have chronic paranasal sinusitis by paranasal sinus X\-ray examination;
  • (2\) Subjects who have organic lesions in the nasal cavity or who have undergone nasal surgery;
  • (3\) Subjects with respiratory tract infection or acute sinusitis within the past 2 weeks; patients with inflammation on chest X\-ray;
  • (4\) Subjects who have received western medicine (H1\-antihistamines, glucocorticoids, leukotriene receptor antagonists, mast cell membrane stabilizers, decongestants and anticholinergics, etc.), traditional Chinese medicines, etc. via nasal cavity, oral cavity or systemic route in the past 2 weeks which may affect the results of clinical study;
  • (5\) Subjects who have received physical therapy within the range of traditional medicine such as acupuncture, moxibustion, cupping, and intranasal Chinese medicine inhalation in the past 2 weeks;
  • (6\) Subjects who have received specific immunotherapy or systemic hormone therapy within the past 1 year;
  • (7\) Subjects complicated with other respiratory diseases, such as asthma, etc.;
  • (8\) Subjects complicated with severe liver or kidney dysfunction or other serious diseases, who cannot receive treatment;
  • (9\) People with serious mental illness or violent tendencies;
  • (10\) Pregnant or lactating women, and women who are planning to become pregnant during the trial;

Outcomes

Primary Outcomes

Not specified

Similar Trials